North Hollywood, California • Velocity Clinical Research
Phone: (818) 487-3741
People with moderate-to-severe atopic dermatitis (a.k.a. eczema) may be eligible to join this research study of an investigational medication. You may receive reasonable reimbursement for participating if you qualify for this study.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — it is your choice if you would like to participate in this research study.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy